Highlights
A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.
Displaying items 1-12 of 20
» View wdbj7.com items only
1
2
•
Next >
-
UPDATE 1-Former Bristol-Myers executive admits to insider trading
Reuters* Robert Ramnarine pleads guilty to securities fraud * Defendant accused of buying options in takeover targets By Jonathan Stempel June 10 (Reuters) - A former Bristol-Myers Squibb Co finance executive on Monday pleaded guilty to an insider trading...Tags: Judges, Justice System, Science and Technology, Bristol Myers Squibb Company, Amylin Pharmaceuticals Incorporated
-
FDA grants priority review status to Gilead's hepatitis C drug
ReutersJune 7 (Reuters) - Biotechnology company Gilead Sciences Inc said the U.S. Food and Drug Administration (FDA) granted priority review to its experimental hepatitis C drug sofosbuvir. The FDA grants priority reviews to medicines that are considered...Tags: Food and Drug Administration, Hepatitis C , Science and Technology, Biotechnology Industry, Biotechnology
-
US STOCKS SNAPSHOT - Early Wall St gains fade; S&P, Nasdaq negative
ReutersNEW YORK, June 3 (Reuters) - U.S. stocks early advance lost steam on Monday, with both the S&P 500 and Nasdaq turning negative on declines in Gilead Sciences and Apple. The Dow Jones industrial average gained 31.50 points, or 0.21 percent, to 15,147.07....Tags: S&P 500, NASDAQ, Nasdaq Composite, Stock Market, Financial Markets
-
Acciones EEUU borran ganancias iniciales; S&P, Nasdaq pasan a negativo
ReutersNUEVA YORK, 3 jun (REUTERS) - El avance inicial de las acciones de Estados Unidos perdía impulso el lunes y los índices S&P 500 y Nasdaq pasaban a territorio negativo debido a bajas de los papeles de Gilead Sciences y Apple. El promedio industrial...Tags: S&P 500, NASDAQ, Nasdaq Composite, Stock Market, Standard & Poor's Financial Services LLC
-
FACTBOX-U.S. biotech shares outpace broader stock market
ReutersMay 28 (Reuters) - Shares of biotechnology companies have outrun a bull market for U.S. stocks, rising nearly 50 percent over the past 12 months as investors look for new growth stories. Investors' enthusiasm, despite the inherent risk of drug...Tags: Vaccines, Schizophrenia, Multiple Sclerosis, Goldman Sachs Group, Inc., Biotechnology Industry
-
ANALYSIS-Biotech's bull run starts to look frothy
ReutersBy Deena Beasley May 28 (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the...Tags: S&P 500, Deutsche Bank AG, Economy, Business and Finance, NASDAQ, Amgen Inc.
-
FDA approves Gilead's four-drug HIV treatment
Reuters(Reuters) - U.S. health regulators on Monday approved Gilead Sciences Inc's four-drug combination pill to treat HIV, the virus that causes AIDS. The four drugs in one pill, which was formerly called the Quad and had been considered one of Gilead's more...Tags: Hepatitis B , AIDS, Truvada, Bristol Myers Squibb Company, HIV
-
FDA Approves First Ever HIV Prevention Drug
KTLA NewsLOS ANGELES -- Adults who do not have HIV but are at risk of getting the disease will now be able to take a drug to reduce their chance of getting infected. For the first time, the U.S. Food and Drug Administration approved a drug for this use on Monday....Tags: Allergies, AIDS, Medical Procedures and Tests, Pharmaceuticals, Truvada
-
AIDS deaths worldwide drop as access to drugs improves
ReutersLOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday. The United Nations...Tags: Vaccines, AIDS, Europe, Politics, International Organizations
-
FDA approves drug to prevent HIV infection
The federal government has approved for the first time a drug that can prevent an HIV infection, a significant development for Baltimore where transmission rates for the virus remain high and growing.
The U.S. Food and Drug Administration approved...Tags: Hospitals and Clinics, Sexually Transmitted Diseases, Hepatitis B , AIDS, Truvada
-
WHO endorses use of HIV medicines for prevention
ReutersNEW YORK (Reuters) - The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it and suggested that poor and wealthy countries alike set up pilot projects to better...Tags: AIDS, International Organizations, Politics, Truvada, United Nations
-
News briefs for Friday, May 11
Biden pushes Obama to declare gay marriage support, then offers his apologies WASHINGTON (AP) — Sorry, Mr. President. After nearly single-handedly pushing gay marriage to the forefront of the presidential campaign and inadvertently pressuring...
Tags: Finance, Music Industry, West Bank, Kid Rock, Politics
Jun 10, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
May 28, 2013
|Story| Reuters
May 28, 2013
|Story| Reuters
Aug 27, 2012
|Story| Reuters
Jul 16, 2012
|Story| KTLA-LTV
Jul 18, 2012
|Story| Reuters
Jul 16, 2012
|Story| Baltimore Sun
Jul 20, 2012
|Story| Reuters
May 11, 2012
|Story| Petoskey News
Original site for Gilead Sciences Inc. topic gallery.